{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:09:46Z","timestamp":1772168986545,"version":"3.50.1"},"reference-count":9,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Solitary mastocytoma, a rare dermatological entity accounts for 10-15% of cutaneous mastocytosis. We report a rare case of solitary mastocytoma presenting at birth, treated successfully with topical tacrolimus. Along with reassurance and strict avoidance of triggering factors, no recurrence was reported within the one year follow-up period.<\/ns4:p>","DOI":"10.12688\/f1000research.3253.1","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T16:12:33Z","timestamp":1406909553000},"page":"181","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Solitary mastocytoma treated successfully with topical tacrolimus"],"prefix":"10.12688","volume":"3","author":[{"given":"M. S.","family":"Sukesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameet","family":"Dandale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachita","family":"Dhurat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Sarkate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Ghate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"ref-1","first-page":"703-717","article-title":"Mastocytosis. In Textbook Of Pediatric Dermatology (Harper J, Oranje A, and Prose N). 2nd Ed. Oxford: Blackwell Scientific","author":"D Van Gysel","year":"2006"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"969-973","DOI":"10.1111\/j.1468-3083.2006.01696.x","article-title":"Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.","volume":"20","author":"G Akoglu","year":"2006","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"41-3","DOI":"10.4103\/0378-6323.38407","article-title":"Adult onset, hypopigmented solitary mastocytoma: report of two cases.","volume":"74","author":"D Kis Pandhi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1275-1280","DOI":"10.1001\/archderm.140.10.1275-e","article-title":"A red-brown plaque on the nape. Solitary mastocytoma.","volume":"140","author":"J Chang","year":"2004","journal-title":"Arch Dermatol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"251-255","DOI":"10.4103\/0973-029X.99081","article-title":"Toluidine blue: A review of its chemistry and clinical utility.","volume":"16","author":"G Sridharan","year":"2012","journal-title":"J Oral Maxillofac Pathol."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"493-500","DOI":"10.1111\/j.1525-1470.2008.00738.x","article-title":"Mastocytosis in children: a protocol for management.","volume":"25","author":"R Heide","year":"2008","journal-title":"Pediatr Dermatol."},{"key":"ref-7","first-page":"1745-1751","article-title":"Cutaneous mastocytosis.","volume":"56","author":"B Flageul","year":"2006","journal-title":"Rev Prat."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"1507-16","DOI":"10.1517\/17425255.2013.819343","article-title":"Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.","volume":"9","author":"H Prucha","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"228-41","DOI":"10.1067\/mjd.2002.120942","article-title":"Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.","volume":"46","author":"P Nghiem","year":"2002","journal-title":"J Am Acad Dermatol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/3-181\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/3-181\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/3-181\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T11:58:07Z","timestamp":1543838287000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/3-181\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":9,"URL":"https:\/\/doi.org\/10.12688\/f1000research.3253.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.3493.r5872","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.3493.r5676","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.3493.r5674","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.3493.r5676","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.3493.r5674","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.3493.r5872","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/3-181\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.3493.r5674, Mohamed Badawy Hassan Tawfik Abdel-Naser, Faculty of Medicine, Ain Shams University, Cairo, Egypt, 05 Aug 2014, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/3-181\/v1#referee-response-5674","order":0,"name":"referee-response-5674","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.3493.r5676, Robert Sidbury, Dermatology Division, Seattle Children's Hospital, Seattle, WA, USA, 19 Aug 2014, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/3-181\/v1#referee-response-5676","order":1,"name":"referee-response-5676","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.3493.r5872, Regina F\u00f6lster-Holst, Dermatologische Klinik, Universit\u00e4t Kiel, Kiel, Germany, 19 Aug 2014, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/3-181\/v1#referee-response-5872","order":2,"name":"referee-response-5872","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication).","order":0,"name":"copyright-info","label":"Copyright"}]}}